196 related articles for article (PubMed ID: 24129196)
1. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening.
Suchanek S; Majek O; Vojtechova G; Minarikova P; Rotnaglova B; Seifert B; Minarik M; Kozeny P; Dusek L; Zavoral M
Eur J Cancer Prev; 2014 Jan; 23(1):18-26. PubMed ID: 24129196
[TBL] [Abstract][Full Text] [Related]
2. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].
Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894
[TBL] [Abstract][Full Text] [Related]
3. [Results of the Czech National Colorectal Cancer screening programme - faecal occult blood tests].
Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
[TBL] [Abstract][Full Text] [Related]
4. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
Leuraud K; Jezewski-Serra D; Viguier J; Salines E
Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
[TBL] [Abstract][Full Text] [Related]
6. [Screening of the sporadic colorectal cancer].
Zavoral M; Závada F
Cas Lek Cesk; 2007; 146(12):950-4. PubMed ID: 18257413
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening in the Czech Republic.
Zavoral M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
9. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
10. Initial results of the National Colorectal Cancer Screening Program in Lithuania.
Poskus T; Strupas K; Mikalauskas S; Bitinaitė D; Kavaliauskas A; Samalavicius NE; Saladzinskas Z
Eur J Cancer Prev; 2015 Mar; 24(2):76-80. PubMed ID: 25370682
[TBL] [Abstract][Full Text] [Related]
11. [Performance indicators in screening programmes].
Májek O; Ngo O; Daneš J; Zavoral M; Dvořák V; Klimeš D; Dušek L
Klin Onkol; 2014; 27 Suppl 2():106-12. PubMed ID: 25494895
[TBL] [Abstract][Full Text] [Related]
12. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
13. The role of primary care in colorectal cancer screening: experience from Czech Republic.
Seifert B; Zavoral M; Fric P; Bencko V
Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening: 20 years of development and recent progress.
Zavoral M; Suchanek S; Majek O; Fric P; Minarikova P; Minarik M; Seifert B; Dusek L
World J Gastroenterol; 2014 Apr; 20(14):3825-34. PubMed ID: 24744575
[TBL] [Abstract][Full Text] [Related]
15. [Population colorectal cancer screening in the Czech Republic].
Zavoral M; Vojtěchová G; Májek O; Ngo O; Grega T; Seifert B; Dušek L; Suchánek Š
Cas Lek Cesk; 2016; 155(1):7-12. PubMed ID: 26898786
[TBL] [Abstract][Full Text] [Related]
16. [Development of indicators to evaluate colorectal cancer prevention programs in the high-risk population: the experience of a high-risk colorectal cancer clinic].
Serra Sutton V; Espallargues M; Balaguer F; Castells A
Gastroenterol Hepatol; 2012 Nov; 35(9):613-24. PubMed ID: 22749512
[TBL] [Abstract][Full Text] [Related]
17. [The populations attitudes to colorectal cancer screening in the Czech Republic].
Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
[TBL] [Abstract][Full Text] [Related]
18. Current screening guidelines overlook a significant number of patients treated for colorectal cancer.
Przybyla AG; Crockett JA; Rex JC; Culumovic PJ
Am Surg; 2014 Jun; 80(6):539-43. PubMed ID: 24887789
[TBL] [Abstract][Full Text] [Related]
19. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
Greuter MJ; Demirel E; Lew JB; Berkhof J; Xu XM; Canfell K; Dekker E; Meijer GA; Coupé VM
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):135-44. PubMed ID: 26598535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
